Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 18086770)

1.

Leukocyte telomere length predicts cancer risk in Barrett's esophagus.

Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, Gallaher JL, Reid BJ, Rabinovitch PS.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2649-55.

2.

The diagnosis and management of Barrett's esophagus.

DeMeester SR, DeMeester TR.

Adv Surg. 1999;33:29-68. Review.

PMID:
10572561
3.

Multiple early esophageal cancers arising from Barrett's esophagus, and a review of cases of early adenocarcinoma in Barrett's esophagus in Japan.

Itatsu T, Miwa H, Murai T, Terai T, Ohkura R, Sorimachi S, Yang SW, Ogihara T, Watanabe S, Hirai S, Sato N.

J Gastroenterol. 1997 Jun;32(3):389-95. Review.

PMID:
9213255
4.

Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.

Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A.

Int J Clin Exp Pathol. 2012;5(5):382-96. Epub 2012 May 23. Review.

5.

[Surveillance of patients with Barrett's esophagus].

Endlicher E, Kn├╝chel R, Messmann H.

Z Gastroenterol. 2001 Aug;39(8):593-600. Review. German.

PMID:
11558064
6.
7.

Advances in Barrett's esophagus and esophageal adenocarcinoma.

Shaheen NJ.

Gastroenterology. 2005 May;128(6):1554-66. Review.

PMID:
15887151
8.

Barrett's esophagus surveillance: When, how often, does it work?

Katona BW, Falk GW.

Gastrointest Endosc Clin N Am. 2011 Jan;21(1):9-24. doi: 10.1016/j.giec.2010.09.003. Review.

PMID:
21112494
9.

Screening and surveillance for complications related to gastroesophageal reflux disease.

Spechler SJ.

Am J Med. 2001 Dec 3;111 Suppl 8A:130S-136S. Review.

PMID:
11749938
10.

Early events during neoplastic progression in Barrett's esophagus.

Reid BJ.

Cancer Biomark. 2010;9(1-6):307-24. doi: 10.3233/CBM-2011-0162. Review.

11.

Dysplasia arising in barrett's esophagus: diagnostic pitfalls and natural history.

Goldblum JR, Lauwers GY.

Semin Diagn Pathol. 2002 Feb;19(1):12-9. Review.

PMID:
11936261
12.

The molecular biology of esophageal adenocarcinoma.

Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN.

J Surg Oncol. 2005 Dec 1;92(3):169-90. Review.

PMID:
16299787
13.

Barrett's esophagus, dysplasia, and adenocarcinoma.

Haggitt RC.

Hum Pathol. 1994 Oct;25(10):982-93. Review.

PMID:
7927321
14.

Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.

Odze RD, Lauwers GY.

Endoscopy. 2008 Dec;40(12):1008-15. doi: 10.1055/s-0028-1103416. Epub 2008 Dec 8. Review.

PMID:
19065484
15.

Influence of genetics on tumoral pathologies: the example of the adenocarcinoma arising in Barrett's esophagus.

Villanacci V, Bassotti G, Salemme M, Rossi E.

Rev Esp Enferm Dig. 2012 Dec;104(11):592-602. Review.

16.

[Endoscopic diagnosis of Barrett's adenocarcinoma].

Yoshio H, Takashi Y, Mitsuyo H, Nobuhiko Y, Tatsurou T, Kazuhiko S, Yoko H, Shigemasa I, Hisanaga M, Osamu H, Katsuyoshi S, Seishi U, Matsushita H, Masahiko T.

Nihon Geka Gakkai Zasshi. 1999 Mar;100(3):244-8. Review. Japanese.

PMID:
10379534
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk